Clinical Trial Update: Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock Trial. VIPER-Sepsis (EudraCT no. 2016-000707-81) [Phase 4]

View source ↗

Summary

Phase 4 trial investigating vasculopathic injury and plasma as endothelial rescue in septic shock (VIPER-Sepsis) was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Septic Shock | Phase 4 | Status: TERMINATED